Panagora Asset Management’s BioTelemetry, Inc. BEAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-30,054
Closed -$1.88M 2766
2019
Q1
$1.88M Buy
+30,054
New +$2.06M 0.01% 862
2017
Q4
Sell
-25
Closed -$1K 2451
2017
Q3
$1K Sell
25
-161,186
-100% -$5.58M ﹤0.01% 2301
2017
Q2
$5.39M Sell
161,211
-91,075
-36% -$2.72M 0.02% 556
2017
Q1
$7.3M Buy
252,286
+11,655
+5% +$289K 0.03% 494
2016
Q4
$5.38M Buy
240,631
+945
+0.4% +$18.5K 0.02% 539
2016
Q3
$4.45M Sell
239,686
-10,817
-4% -$204K 0.02% 586
2016
Q2
$4.08M Buy
250,503
+14,677
+6% +$216K 0.02% 619
2016
Q1
$2.75M Buy
235,826
+50,460
+27% +$564K 0.01% 759
2015
Q4
$2.17M Buy
185,366
+25,540
+16% +$323K 0.01% 797
2015
Q3
$1.96M Buy
159,826
+25,597
+19% +$326K 0.01% 773
2015
Q2
$1.27M Buy
134,229
+6,210
+5% +$57.5K 0.01% 990
2015
Q1
$1.13M Buy
128,019
+31,291
+32% +$316K 0.01% 1016
2014
Q4
$970K Buy
96,728
+1,011
+1% +$8.67K 0.01% 1055
2014
Q3
$642K Buy
95,717
+53,372
+126% +$374K ﹤0.01% 1220
2014
Q2
$304K Buy
42,345
+3,148
+8% +$25.1K ﹤0.01% 1564
2014
Q1
$395K Buy
+39,197
New +$361K ﹤0.01% 1511

Other funds holding BEAT

Panagora Asset Management's BEAT Position: Q2 2019 in Review

Panagora Asset Management sold out of BioTelemetry, Inc. (BEAT) in Q2 2019, closing a stake of 30,054 shares — an estimated $1.88M sold.

Panagora Asset Management first reported a position in BEAT in Q1 2014 and held it in 16 quarters. The position peaked at $7.3M in Q1 2017. 251 funds tracked by Wall St. Rank hold BEAT as of Q2 2019.

  • Panagora Asset Management reported no remaining BioTelemetry, Inc. position as of Q2 2019 after selling out during the quarter.
  • Panagora Asset Management sold 30,054 BioTelemetry, Inc. shares in Q2 2019, an estimated $1.88M.
  • Panagora Asset Management first reported a position in BioTelemetry, Inc. in Q1 2014 and held it in 16 quarters.
  • Panagora Asset Management's BioTelemetry, Inc. position peaked at $7.3M in Q1 2017.
  • 251 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q2 2019.

Based on Panagora Asset Management's 13F filing for Q2 2019, filed 9 Aug 2019.